NICE's methodology means people with cancer aren't getting drugs - AstraZeneca's Sir Pascal Soriot said
The chief executive of AstraZeneca has criticised a public health body for refusing to make one of its breast cancer treatments available to NHS patients in England and Wales.
The full article is no longer available.
');
//-->